POS-041 BCX9930, AN ORAL FACTOR D INHIBITOR, SUPPRESSES COMPLEMENT ALTERNATIVE PATHWAY ACTIVITY IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHYX. Chen,C. Parker,J. Wang, F. Zhu, M. Cornpropst,W. Sheridan,Y. Babu,M. Davidson, C. NesterKidney International Reports（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
